The intranasal GHK-Cu treatment was found to delay cognitive impairment, reduce amyloid plaques, and lower inflammation levels in the frontal cortex and hippocampus .37 Randomized controlled trials in human patients are needed to confirm the benefit of GHK-Cu for cognitive decline and Alzheimers disease as well as to evaluate safe and effective human dosing (the human dose equivalent of 15mg/kg in mice would be ~1.2mg/kg, though data on this or any other dosing nasally in humans is not currently available), but preliminary animal trials are promising
Rob Williams Fact-Checker Rob Williams is a longtime copy editor whose clients over the years have included Time Inc., Cond Nast, Rodale, and Wenner Media, as well as various small and midsize companies in
The positive impact that apigenin has on the guts then is that it promotes a healthy microbiome, repairs intestinal genes, and acts as an anti-inflammatory
Stasinopoulos, A controlled clinical pilot trial to study the effectiveness of ice as a supplement to the exercise programme for the management of lateral elbow tendinopathy, British journal of sports medicine 40, no
